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Abstract
Background: Phage display is widely used in basic research such as the exploration of protein-
protein interaction sites and networks, and applied research such as the development of new drugs,
vaccines, and diagnostics. It has also become a promising method for epitope mapping. Research
on new algorithms that assist and automate phage display based epitope mapping has attracted
many groups. Most of the existing tools have not been implemented as an online service until now
however, making it less convenient for the community to access, utilize, and evaluate them.
Results: We present MIMOX, a free web tool that helps to map the native epitope of an antibody
based on one or more user supplied mimotopes and the antigen structure. MIMOX was coded in
Perl using modules from the Bioperl project. It has two sections. In the first section, MIMOX
provides a simple interface for ClustalW to align a set of mimotopes. It also provides a simple
statistical method to derive the consensus sequence and embeds JalView as a Java applet to view
and manage the alignment. In the second section, MIMOX can map a single mimotope or a
consensus sequence of a set of mimotopes, on to the corresponding antigen structure and search
for all of the clusters of residues that could represent the native epitope. NACCESS is used to
evaluate the surface accessibility of the candidate clusters; and Jmol is embedded to view them
interactively in their 3D context. Initial case studies show that MIMOX can reproduce mappings
from existing tools such as FINDMAP and 3DEX, as well as providing novel, rational results.
Conclusion: A web-based tool called MIMOX has been developed for phage display based epitope
mapping. As a publicly available online service in this area, it is convenient for the community to
access, utilize, and evaluate, complementing other existing programs. MIMOX is freely available at
http://web.kuicr.kyoto-u.ac.jp/~hjian/mimox.
Background
Since the pioneering work of Smith and co-workers [1-3],
phage display technology has been widely used in both
basic research such as the exploration of protein-protein
interaction sites and networks [2-5], and applied research
such as the development of new drugs, diagnostics, and
vaccines [6-8]. Phage display has also become a promising
epitope mapping method, which has been applied in
many fields such as allergology[9] and oncology[10]. The
phage display based epitope mapping is usually accom-
plished through comparing the sequence of mimotopes
(antibody-selected phage displayed peptides) to the anti-
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gen. In some cases, the mimotope sequence is identical or
very similar to a sequence in the antigen[2], there by indi-
cating the location of the native epitope. These cases are
rare however, and usually the mimotope sequence has lit-
tle, if any, similarity with the antigen sequence. Compared
with traditional epitope mapping methods such as solv-
ing the crystal structure of the antigen-antibody complex
or scanning overlapping peptides of the antigen, phage
display based epitope mapping is generally much cheaper
and less arduous.
Though epitope mapping based on phage display can be
done manually[11], it is quite tedious and time-consum-
ing to compare a set of mimotopes to the antigen without
computational support. The low sequence similarity
between the mimotope and the antigen often makes the
mapping even harder. To solve these problems, several
groups have researched algorithms and programs that
assist and automate phage display based epitope mapping
[12-17]. According to their dependency on antigen struc-
ture, the existing programs for phage display based
epitope mapping can be classified into three categories.
Program in the first category such as FINDMAP, only work
with sequence data from the mimotopes and antigen[13].
The second category needs both the sequence data and the
antigen structure. SiteLight[12], 3DEX[14], and Map-
itope[16,17] belong to this category. A very recently pub-
lished work: MIMOP[15] makes the third category, which
integrates the two different approaches and can work with
or without the antigen structure. Though implemented
differently, all the existing programs have succeeded in
given cases. However, most of the existing tools have not
been implemented as a freely available online service
until now, making it less convenient for the community to
access, utilize, and evaluate them.
In the present study, we describe a web-based tool for
phage display based epitope mapping named MIMOX. It
was coded with Perl as a CGI program and can be used to
align a set of mimotopes and derive a consensus sequence.
The consensus sequence, or a single mimotope sequence,
can then be mapped on to the antigen structure, and
potential epitopes determined by spatial clustering of the
mapped residues. The results mapped on to the antigen's
3D structure can then be viewed interactively. To validate
this web-based tool, we compared the results from
MIMOX with the results from other computational tools
and experimentally identified native epitopes in several
case studies.
Implementation
Overall architecture of MIMOX
MIMOX was coded with Perl using modules from the
Bioperl[18] project. The whole online service provided by
MIMOX is accomplished through a set of CGI scripts. The
MIMOX service can be divided into two main sections. In
the first section, MIMOX provides a simple interface for
ClustalW[19] to align a set of mimotope sequences; this is
implemented as the script mimosa.pl. The alignment can
then be used to derive the consensus sequence through a
simple statistical method; this is implemented as the
script mimocs.pl. The alignment can also be viewed and
managed through an embedded Java applet version of
JalView[20]; this is implemented as the script jalviews.pl.
In the second section, MIMOX tries to map the user sup-
plied sequence on to the given antigen structure. This is
implemented as the script mimox.pl. The program NAC-
CESS[21] is also wrapped into mimox.pl and used to calcu-
late the surface accessibility of the mapping results. All
mapping results are ranked based on their solvent accessi-
ble surface. Each mapping result has detailed information
of the accessibility of each candidate residue, which is
parsed through the script parsa.pl and displayed as a table
in a new window. Each mapping result can also be viewed
interactively on the antigen structure. This is implemented
as the script jmol.pl, which wraps a Java applet version of
Jmol[22]. The overall architecture of MIMOX is shown
schematically in Figure 1.
Deriving consensus sequence from a set of mimotopes
As described above, MIMOX wraps ClustalW to align a set
of mimotope sequences and then allows the alignment to
be viewed, edited, and analyzed through an embedded
version of JalView. Based on the review by Smith et al [3],
we also implemented a simple statistical method in the
script mimocs.pl to derive a consensus sequence from the
alignment. Firstly, the script counts the appearance of
each kind of amino acid at each position in the alignment
and calculates the percentage frequency of each one. The
frequency of a given amino acid X at the position i of the
alignment (fxi) is defined as
where Xi means the times that the given amino acid X
appears at the position i of the alignment and N is the
number of sequences in the alignment. All frequencies are
compared to a threshold value, which is 25% by default.
If a frequency is more than the threshold, the correspond-
ing residue is considered as a motif residue at that posi-
tion. If the sum frequency of similar residue at the same
position is above the threshold, the similar residues are
also regarded as motif residues. In MIMOX, there are five
similar residue groups (L, I, V; T, S; E, D; Q, N; K, R; F, W);
other residues are considered unique. This classification
scheme is the same as that used by Mapitope[16,17]. If no
motif residue is found at a given position, then X is used
to stand for any amino acid residue. Motif residues at all
positions of the alignment are then displayed in a table.
f
Xi
N
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Overall architecture of MIMOX Figure 1
Overall architecture of MIMOX. MIMOX has two sections. The first section has 3 perl scripts. The script mimosa.pl aligns a set 
of mimotope sequences powered by ClustalW. The script jalviews.pl wraps JalView to view and manage the alignment. The 
script mimocs.pl derives a consensus sequence from the alignment. The second section also has 3 perl scripts. The script 
mimox.pl maps the user supplied sequence on to the given antigen structure and utilizes NACCESS to calculate the accessibility. 
The script parsa.pl displays the detailed accessibility information of each mapping result. The script jmol.pl wraps Jmol to view 
the mapping result interactively on the antigen structure.
Section 2 
Section 1  Sequence of a set of mimotopes 
mimosa.pl (ClustalW) 
mimocs.pl  jalview.pl (JalView) 
Consensus sequence 
mimox.pl+(NACCESS) 
jmol.pl (Jmol)  parsa.pl 
Mapping results 
Display detailed 
accessibility data 
View in antigen 
structure context 
PDB File 
Alignment 
Input fragment or  
full sequence directly BMC Bioinformatics 2006, 7:451 http://www.biomedcentral.com/1471-2105/7/451
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Thus a consensus sequence is suggested by the program.
The script also creates a 3D bar figure based on the statis-
tical analysis above, where the X axis represents the 20
amino acid types and gap type, Y axis is the frequency and
Z axis stands for the position of the aligned sequences
(Shown in Figure 2).
Mapping sequence to the corresponding antigen structure
Since the mimotopes and the native epitope on the anti-
gen bind to the same antibody, it is assumed that the
mimotopes and the native epitope have similar physico-
chemical properties and similar spatial organization. This
assumption is the basis of the MIMOX algorithm. The
mapping process of MIMOX is based on the input
sequence (such as the consensus sequence) and the
uploaded antigen structure. A fragment of the sequence
can also be used as input.
Firstly, for each position in the input sequence, MIMOX
searches the uploaded PDB structure for matching resi-
dues and places them into an array of candidate residues
for that position. Two matching modes are available at
present. One is strict mode, which means the type of mim-
otope residue must match the antigen residue exactly. The
other is called conservative mode, which means similar
residues are also included in the candidate residue array.
There are 5 groups of similar residues (L, I, V; T, S; E, D; Q,
N; K, R; F, W) in MIMOX, which has been described in
previous section.
Web interface of MIMOX section 1 Figure 2
Web interface of MIMOX section 1. Mimotopes selected out with trastuzumab[10] are input and aligned with wrapped Clus-
talW. The frequency of a given amino acid at each position of the alignment is calculated and displayed in a table. A 3D bar fig-
ure is also created, where the X axis represents the 20 amino acid types and gap, Y axis is the frequency and Z axis stands for 
the position of the aligned sequences. A consensus sequence is then suggested, which can be used in further mapping with 
MIMOX. The alignment can also be managed with the embedded JalView[20].BMC Bioinformatics 2006, 7:451 http://www.biomedcentral.com/1471-2105/7/451
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The array of candidate residues for each position is then
added to an array of arrays. MIMOX finds all the residue
neighbour pairs between consecutive candidate residue
arrays in the array of arrays. Whether two residues are
neighbours is determined by the distance between the two
residues and the distance threshold value. If the distance
between two residues is below the threshold, the two res-
idues are taken as a neighbour pair. MIMOX provides
three methods to calculate neighbour residue pairs. One
method is to take the distance between the Cα atoms of
the two amino acids as the distance between the two resi-
dues. Using Cα atoms may better reflect the backbone
positions. The second method is to use the distance
between the Cβ atoms, which may better reflect the side
chain position (Cα atom is still used when it is a glycine
because it does not have a Cβ atom). The third method
described below, is based on the distances between all the
heavy atoms of the two amino acids. All of the distances
mentioned above are Euclidean distances, calculated as:
where D21 means the distance between atom 2 and atom
1 and x2, y2, z2, x1, y1, z1 are coordinates of atom 2 and
atom 1. When the methods based on Cα or Cβ atom posi-
tion are used, the default distance threshold is 7.0 ang-
stroms, as it approximates the upper limit for noncovalent
interactions in macromolecular structures[23]. When the
third method is used, the distance threshold is calculated
as
DT = DF × (vdwAtom1 + vdwAtom2)
where DT is the distance threshold, DF is the Distance Fac-
tor (given by user), and vdwAtom is the Van der Waals
radius of the atom. The default DF value is 1.11. If two res-
idues have a pair of heavy atoms which are nearer than the
distance threshold calculated from their Van der Waals
radius, the two residues are taken as a neighbour pair.
MIMOX then recursively links the neighbour pairs until
all possible ways of forming the input sequence are made.
Each result is then ranked according to the sum of the
absolute residue accessibility of each residue calculated
from the NACCESS result file. In the end, the results are
displayed in a table with hyperlinks to call the script
parsa.pl which can parse and display the accessibility data
in detail, and the script jmol.pl to view the result interac-
tively mapped onto the antigen structure.
Results and discussion
Web interface of MIMOX
MIMOX has successfully been implemented as an online
service, which has a simple web interface both for input
and output. As described previously, MIMOX can be
divided into two sections; we show here the input and
output of the two sections in Figure 2 and Figure 3 respec-
tively.
Case studies
To test MIMOX, we have applied it to several cases taken
from other similar research and literature. We compared
the results from MIMOX with the results from other com-
putational tools and the native epitope itself if the epitope
is known in the CED database[24]. It should be pointed
out that cases using monoclonal antibodies are most
appropriate for testing[15]. However, in order to compare
with previously published tools, some less appropriate
cases (using polyclonal antibodies) taken from the corre-
sponding literature are also used. More case studies [see
Additional file 1] can also be found on the test dataset
page of MIMOX[25].
The first case is taken from FINDMAP[13]. In 1999,
Jesaitis and co-workers used an anti-actin polyclonal anti-
body to select a phage displayed random peptide library;
VPHPTWMR was one of the consensus sequences they
derived from the selected mimotopes. They manually
mapped VPHPTWMR to the known structure of actin
[PDB: 1ATN] and suggested that it might correspond to
residues: V129, P130, H101, P102, T358, W356, M355,
R372[11]. In 2003, Mumey et al used FINDMAP to align
VPHPTWMR to the actin sequence without utilizing infor-
mation on the antigen structure. The result from FIND-
MAP shows VPHPTWMR can be mapped to residues as
V129, P130, H101, P102, T103, W356, M355, R372[13].
FINDMAP mapped the input sequence to a slightly differ-
ent set of residues (using T103 instead of T358). When
running MIMOX with all parameters as defaults, we got
no result. However, after the distance threshold is
changed to 12 Å (the maximum distance allowed in
MIMOX), we find that the two mappings above are
returned as candidate cluster 5 and candidate cluster 17.
As the side chain of some amino acids (such as arginine)
can span a distance as great as 12 Å, MIMOX takes this
value as the maximum allowable distance. This distance
restriction is also used by Mapitope[16,17]. In this case,
the need for the higher distance threshold is due to R372
which lies some distance from the other mapped residues.
MIMOX also suggested other possibilities such as cluster
1(V96, P102, H101, P130, T358, W356, M355, R372)
which has a bigger solvent accessible surface, and cluster
26 (V96, P98, H101, P102, T103, W356, M355, R372),
which clearly has 3 sequential segments, i.e. VPHPT, WM,
and R.
The second case is taken from work by Enshell-Sei-
jffers[16]. They used monoclonal antibody 17b, which is
against HIV gp120 envelope glycoprotein, to select a
phage displayed random peptide library and got a set of
Dx x y y z z 21 2 1
2
21
2
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11 mimotopes. Analyzing the mimotopes with Mapitope,
they suggest that the 17b epitope might consist of the fol-
lowing residues and segments: L111, LKPCVK (116–121),
P124, VITQ (200–203), CPKV (205–208), RIK (419–
421), I423, I424, K432, P437, P438. The structure of HIV
gp120 envelope glycoprotein in complex with 17b has
Web interface of MIMOX section 2 Figure 3
Web interface of MIMOX section 2. LLTTNKD[14] is mapped to the HIV gp120 envelope glycoprotein via MIMOX. When 
picking candidate residues in conservative mode and all other parameters in defaults, a new top result is suggested. The 
detailed accessibility data and the image of the new mapping result are dispaleyed accordingly.BMC Bioinformatics 2006, 7:451 http://www.biomedcentral.com/1471-2105/7/451
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been solved [PDB: 1GC1] and 17b epitope has been
recorded in the CED database as CE0058, which is com-
posed of CK(119,121) + VTQAC(200,202–205) +
RKQI(419,421–423) + KMYP (432,434,435,437). Among
the 24 Mapitope predicted residues, 11 are contact resi-
dues of the 17b epitope. Using default parameters,
MIMOX derived a consensus sequence, [LV] RP [LT] [KR]
LRE [LP] [RT] X [-R], from 17b mimotopes. MIMOX finds
no result matching the whole consensus sequence. Using
LRLR, a fragment of the consensus sequence as the input
sequence and running MIMOX in conservative match
mode with other parameters as defaults, the top result is
I423, K421, I420, and R419; the 4th result is V200, K121,
L122, K432 and the 5th result is I423, K432, L122, and
K121. Taking the top 5 results together, 13 residues are
suggested by MIMOX and 6 of them are contact residues
of the 17b epitope. In this case, Mapitope gives more com-
plete and elaborate result.
The third case is taken from 3DEX[14]. LLTTNKD is a
mimotope selected from a phage displayed random pep-
tide library using HIV positive patients' IgG. Using 3DEX
to map this mimotope to the HIV gp120 envelope glyco-
protein [PDB: 1G9M], Schreiber et al reported that this
mimotope might correspond to residues: L452, L453,
T283, T455, N280, K282, and D279. When running
MIMOX with default parameters, the top candidate resi-
due cluster is exactly the same as the result of 3DEX, which
has a 265.82 Å2 solvent accessible surface. By picking can-
didate residues in conservative mode and clustering based
on Cα atoms with a distance threshold 7 Å, the top candi-
date residue cluster suggested by MIMOX is changed to
I360, I467, S465, T358, N356, K357, and E464. This clus-
ter has a 399.28 Å2 accessible surface area. Furthermore,
when neighbouring based on all heavy atoms with a dis-
tance factor 1.11, the top candidate residue cluster sug-
gested by MIMOX is L86, V85, T244, S243, N229, K231,
and E267, which has an even larger accessible surface area,
562.89 Å2. All 3 clusters are shown in Figure 4. As the lat-
ter two mapping results suggested by MIMOX are more
exposed, they might be able to bind to the antibody more
easily.
The last case is taken from MIMOP[15]. BO2C11 is a
human monoclonal antibody against human coagulation
factor VIII. Villard et al selected two phage displayed ran-
dom peptide libraries with BO2C11 and got a set of 27
mimotopes[26]. Very recently, Moreau et al have applied
their newly developed tool MIMOP to analyze these mim-
otopes. Combining the two methods MimAlign and Mim-
Cons in MIMOP, the BO2C11 epitope is predicted be
composed of a segment YFTNMF (2195–2200) and resi-
dues T2202, K2207, R2215, R2220, Q2222. The structure
of human coagulation factor VIII in complex with
Comparison of three mapping results Figure 4
Comparison of three mapping results. MIMOX was used to map LLTTNKD to HIV gp120 with three different methods. The 
top result using the default parameters is shown in image A. It is composed of the residues: L452 L453 T283 T455 N280 K282 
D279 and has a 265.82 Å2 solvent accessible surface. The top result from conservative mode is shown in image B. It is com-
posed of the residues: I360 I467 S465 T358 N356 K357 E464, with a 399.28 Å2 surface area. Image C shows the top result 
from the all heavy atoms method. It is composed of the residues: L86 V85 T244 S243 N229 K231 E267 and has an even larger 
accessible surface area of 562.89 Å2.BMC Bioinformatics 2006, 7:451 http://www.biomedcentral.com/1471-2105/7/451
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BO2C11 has been solved [PDB: 1IQD] and the BO2C11
epitope has been recorded in the CED database as
CE0176, which consists of FTNMF (2196–2200), R2215,
RPQV (2220–2223), SLLT (2250–2253), HQ (2315–
2316). Using default parameters, MIMOX derived a con-
sensus sequence of [NQKR] [HST] RWSNRSS [ST] from
those mimotopes. Again, the whole length consensus
sequence returns no mapping results. However, when we
use QH, RWSN, RSSS, three sequential fragments that
cover the whole consensus sequence, as input sequences
and running MIMOX in conservative match mode with all
other parameters as defaults, the top 3 results of each of
the partial sequences overlap with the MIMOP result and
the native BO2C11 epitope well. For example, the third
result of the input QH suggested by MIMOX is Q2316,
H2315; the third result of the input RWSN suggested by
MIMOX is R2220, F2196, T2197, N2198; the first result of
the input RSSS suggested by MIMOX is R2215, S2216,
T2202, T2197 and third result is K2249, S2250, S2254,
T2253.
Taking together, our initial case studies show that MIMOX
can fully or partially repeat results from manual mapping,
other existing tools, and also provide novel suggestions.
MIMOX is designed to be a tool which is more interactive
than automatic. We acknowledge that tuning the probe
sequences and parameters are often required to get good
results. This interactive process gives hints to users step by
step and greatly decreases the load of the server and pre-
vents the loss of some reasonable results. MIMOX lists all
the matched results with no prediction threshold. This
allows users to find the reasonable results by themselves
based on their background knowledge on a given anti-
body, a given antigen and a given phage display experi-
ment. Nevertheless, according to the test dataset page of
MIMOX, the true epitope (or its segments) often falls in
the top 5 (if the there are only a few result entries) or top
10% (if the there are many result entries) of the results.
Where the real epitope is unknown, we would suggest
running MIMOX with a range of parameters and consen-
sus sequence derived fragments to find overlapping or
otherwise promising (high surface accessibility) candi-
date.
Related software comparison
As we have mentioned previously, several groups have
researched algorithms and programs that may assist and
automate phage display based epitope mapping. Based on
the dependency on antigen structure, the existing pro-
grams can be classified into three categories. FINDMAP
belongs to the first category, which is independent of any
structural information. FINDMAP has been implemented
as a C++ program. It aligns a probe (e.g. a consensus
sequence derived from a set of mimotopes) to the
sequence of native antigen, allowing any permutation of
the probe sequence. It uses a two-part scoring system to
evaluate the quality of alignments and a branch-and-
bound algorithm to find an alignment with maximum
score[13].
The programs in the second category include SiteLight,
3DEX, Mapitope, and MIMOX. SiteLight was imple-
mented in C++ and it has been tested on Red Hat Linux.
First, the program divides native protein surface into over-
lapping patches based on geodesic distances between res-
idues; then aligns each mimotope in the library with each
patch and scores and sorts them; finally, high scoring
matches are selected iteratively until 25% of the native
protein is covered[12]. Another program 3DEX was
implemented in Visual Basic and could only run on Win-
dows. It divides a sequence into a set of overlapping sub-
sequences with a user-defined length (3-maximum length
of mimotope). Then, it searches for matching residues at
each position of the above subsequences against the
sequence or PDB structure of native protein and links the
neighbours iteratively until the first subsequence is com-
plete. This is repeated for the following subsequences to
complete the mimotope and return the result[14]. Map-
itope was also implemented in C++ and its algorithm was
first described by Enshell-Seijffers in 2003. Briefly, Map-
itope deconvolutes a set of mimotope sequences into a set
of overlapping amino acids pairs (AAP). Then a set of
major statistically significant pairs (SSP) are identified
based on the AAP. Later, the SSP are mapped and clustered
in the antigen structure. Finally, the most elaborate and
diverse clusters on the antigen surface are identified and
regarded as the predicted epitope candidates[16,17].
Table 1: Comparing available programs related to MIMOX
SiteLight FINDMAP 3DEX MIMOP Mapitope MIMOX
Coded in C++ C++ VB PHP C++ Perl
Operating System Linux Not stated Windows Platform independent Windows Platform independent
Interface Command Line Not stated Graphic Web Command Line Web
Online Service no no no available on request under construction available
Structure Dependent yes no yes yes/no yes yesBMC Bioinformatics 2006, 7:451 http://www.biomedcentral.com/1471-2105/7/451
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MIMOP, a work published very recently, comprises the
third category. MIMOP includes two approaches. One is
called MimAlign, which can predict potential epitopic
regions (PER) from mimotope and antigen sequences,
and from the antigen structure if available. The other
called MimCons, can predict PER from mimotope
sequences but requires the antigen structure[15]. It seems
that MIMOP can work with or without the antigen struc-
ture from the published case studies. However, the
sequence of the only case that is independent of antigen
structure is just a continuous subsequence of the antigen
sequence. Thus, more studies are still needed to prove that
MimAlign can work without antigen structure informa-
tion.
All the existing programs described above have succeeded
in given cases. However, a systematic evaluation on these
tools is absent. Moreover, as shown in the Table 1, most
of the existing tools have not been implemented as a pub-
licly accessible online service until now, making it less
convenient for the community to access, utilize, and eval-
uate them.
Future work
Like all software, bugs will have crept into MIMOX during
the programming. We expect users will send their feed-
back to help us maintain and improve MIMOX in the
future. A new version of MIMOX with more user definable
options and supporting multiple-chain antigens will be
implemented in the future, allowing epitopes formed by
residues from different polypeptide chains to also be pre-
dicted. A systematic evaluation and comparison study
with all available tools including MIMOX that assist
phage display based epitope mapping is also under our
consideration.
Conclusion
MIMOX, a web application for phage display based
epitope mapping has been coded with Perl. It is helpful
for molecular biologists to identify the native epitope of
an antibody based on the antigen structure and a set of
mimotope sequences they get through phage display tech-
nology. As a publicly accessible web tool in this area,
MIMOX is very convenient for the community to access,
utilize, and evaluate, complementing other existing pro-
grams.
Availability and requirements
Project Name: MIMOX
Project Homepage: http://web.kuicr.kyoto-u.ac.jp/
~hjian/mimox
Operating System: Platform independent
Programming Language: Perl
Other Requirements: Java1.2 or higher
License: GNU GPL
Any Restrictions to use by non-academics: none
Abbreviations
CGI: Common Gateway Interface; GNU: GNU's Not
UNIX; GPL: General Public License; HIV: Human Immu-
nodeficiency Virus; MIMOX: MIMOtope eXplorer; PDB:
Protein Data Bank; PHP: Hypertext Preprocessor; VB: Vis-
ual Basic
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